Gujarat-based penny stock under Rs 1: Board announces record date for 1:10 bonus shares!

DSIJ Intelligence-1 / 24 Jul 2025/ Categories: Penny Stocks, Trending

Gujarat-based penny stock under Rs 1: Board announces record date for 1:10 bonus shares!

The stock is up over 70 per cent from its 52-week low of Rs 0.52 per share.

Murae Organisor Ltd, an Ahmedabad-based company, has recommended the issuance of bonus shares in a 1:10 ratio, meaning one new fully paid-up equity share of Re 1 for every ten existing fully paid-up equity shares of Re 1. This bonus issue, which will capitalise Rs 1858.96 lakh from the company's securities premium account received in cash and/or free reserves available as of March 31, 2025, aims to increase the paid-up share capital from 1,85,89,64,310 equity shares to 2,04,48,60,741 equity shares, each valued at Re 1. The Board fixed the record date as Tuesday, July 29, 2025.

Earlier, Murae Organisor secured Rs 297 crore in agri-commodity supply orders from domestic clients for items like mustard seeds and pulses, with a Rs 57 crore tranche executable in 30 days. Additionally, the company plans to invest Rs 20-25 crore in acquiring agricultural land in Kutch, Gujarat, to cultivate pomegranates and establish a distillery, aiming for sustainable long-term growth and portfolio diversification.

DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.

About the Company

Murae Organisor Ltd, incorporated in 2012, operates within the pharmaceutical industry, focusing on the marketing, trading, and distribution of a diverse range of pharmaceutical formulations. The company markets over 120 products under its brand names, such as HYGNEX+, Erolon, and Calcybar, while outsourcing its manufacturing to third-party facilities. In addition to their branded products, Murae also trades in active pharmaceutical ingredients. Their product portfolio spans various therapeutic categories, including antibiotics, antimalarials, antihistamines, analgesics, dermatology products, neurological drugs, gastrointestinal drugs, and various supplements like calcium and multivitamins. Murae maintains an international presence, exporting to more than 15 countries across North America, CIS, Latin America, Africa, and Southeast Asia, with over 60 international products currently under registration.

According to Quarterly Results, the net sales increased by 59,845 per cent to Rs 515.53 crore and net profit increased by 144 per cent to Rs 2.85 crore in Q4FY25 compared to Q4FY24. In its annual results, the net sales increased by 33,554 per cent to Rs 854.82 crore and net profit increased by 14,940 per cent to Rs 7.52 crore in FY25 compared to FY24

The company has a market cap of Rs 165 crore and its 100 per cent stake is owned by public shareholders. The stock is up over 70 per cent from its 52-week low of Rs 0.52 per share.

Disclaimer: The article is for informational purposes only and not investment advice.